This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acquisition Of Emeritus Corporation By Brookdale Senior Living Inc. May Not Be In Shareholders' Best Interests

SAN DIEGO and SEATTLE, Feb. 21, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Emeritus Corporation (NYSE: ESC) by Brookdale Senior Living Inc. (NYSE: BKD). On February 20, 2014, the companies announced the signing of a definitive agreement pursuant to which Emeritus shareholders will receive 0.95 shares of Brookdale common stock in exchange for each share of Emeritus common stock, a cash value of $28.59 per share.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO)

Is the Proposed Merger Best for Emeritus and Its Shareholders?

Robbins Arroyo LLP's investigation focuses on whether the board of directors at Emeritus is undertaking a fair process to obtain maximum value and adequately compensate Emeritus shareholders.  As an initial matter, there are currently three analysts with target prices higher than the $28.59 merger consideration, including an analyst at Sidoti & Company who set a price of $31.00 on February 5, 2014.

In addition, on February 20, 2014, Emeritus released its financial results for the fourth quarter and full year 2013, reporting solid increases in community, ancillary services, and management fee revenue as well as in adjusted EBITDAR. Specifically, Emeritus reported that the company's community, ancillary services, and management fee revenue increased $101.2 million, or 24.6%, for the quarter and $541.7 million, or 39%, for the year compared to the same periods in 2012. Similarly, Emeritus reported robust increases in adjusted EBITDAR showing a quarterly increase of $29.8 million, or 25.6%, and an annual increase of $141.6 million, or 36.3%, compared to the same periods in 2012. 

Further, in connection with entering into the Merger Agreement, Daniel R. Baty, the Chairman of the Board of Emeritus, and certain of his affiliates who collectively own 12.1% of the total shares of Emeritus common stock agreed to vote their shares of Emeritus common stock (i) in favor of the approval of the Merger Agreement and (ii) against any alternative acquisition proposals.

Given these facts, Robbins Arroyo LLP is examining the Emeritus board of directors' decision to sell the company to Brookdale now rather than allow shareholders to continue to participate in the company's continued success and future growth prospects. 

Emeritus shareholders have the option to file a class action lawsuit to ensure the board of directors obtains the best possible price for shareholders and the disclosure of material information.  Emeritus shareholders interested in information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, ddonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The law firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.   

Attorney Advertising. Past results do not guarantee a similar outcome.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs